466 related articles for article (PubMed ID: 36350516)
1. The Role of DNA Methylation and DNA Methyltransferases in Cancer.
Weisenberger DJ; Lakshminarasimhan R; Liang G
Adv Exp Med Biol; 2022; 1389():317-348. PubMed ID: 36350516
[TBL] [Abstract][Full Text] [Related]
2. The Role of DNA Methylation in Cancer.
Lakshminarasimhan R; Liang G
Adv Exp Med Biol; 2016; 945():151-172. PubMed ID: 27826838
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.
Liang G; Weisenberger DJ
Epigenetics; 2017 Jun; 12(6):416-432. PubMed ID: 28358281
[TBL] [Abstract][Full Text] [Related]
4. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
Weisenberger DJ; Liang G; Lenz HJ
Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development.
Pires SF; de Barros JS; da Costa SS; de Oliveira Scliar M; Van Helvoort Lengert A; Boldrini É; da Silva SRM; Tasic L; Vidal DO; Krepischi ACV; Maschietto M
Mol Genet Genomics; 2023 May; 298(3):721-733. PubMed ID: 37020053
[TBL] [Abstract][Full Text] [Related]
9. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer.
Gao D; Herman JG; Guo M
Oncotarget; 2016 Jun; 7(24):37331-37346. PubMed ID: 26967246
[TBL] [Abstract][Full Text] [Related]
11. Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer.
Soozangar N; Sadeghi MR; Jeddi F; Somi MH; Shirmohamadi M; Samadi N
J Cell Physiol; 2018 May; 233(5):3968-3981. PubMed ID: 28888056
[TBL] [Abstract][Full Text] [Related]
12. [DNA methylation. From basic research to routine diagnostics].
Lehmann U
Pathologe; 2010 Oct; 31 Suppl 2():274-9. PubMed ID: 20824434
[TBL] [Abstract][Full Text] [Related]
13. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis.
Casalino L; Verde P
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806509
[TBL] [Abstract][Full Text] [Related]
14. DNA hypomethylation in cancer cells.
Ehrlich M
Epigenomics; 2009 Dec; 1(2):239-59. PubMed ID: 20495664
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation in bladder cancer: biological pathways and translational applications.
Sánchez-Carbayo M
Tumour Biol; 2012 Apr; 33(2):347-61. PubMed ID: 22274923
[TBL] [Abstract][Full Text] [Related]
16. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
17. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
19. Quercetin modifies 5'CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells.
Kedhari Sundaram M; Hussain A; Haque S; Raina R; Afroze N
J Cell Biochem; 2019 Oct; 120(10):18357-18369. PubMed ID: 31172592
[TBL] [Abstract][Full Text] [Related]
20. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
